香港快運完成數字健康護照CommonPass測試
香港快運(HK Express)公布,為準備迎接旅遊新常態,近日已完成數字健康護照CommonPass應用程式的首次測試。該應用程式可安全驗證及儲存用戶的新型冠狀病毒病檢測結果與疫苗接種記錄,核實並確認各國入境要求,方便旅客掌握出境程序。
香港快運於5月6日由香港飛往台中的UO172航班進行測試,機師及機組人員屬自願參與,透過建立用戶個人檔案,並在起飛前24至72小時進行病毒快速測試,由指定化驗所Prenetics進行樣本化驗,應用程式在於24小時內取得檢測結果,以作識別。為保障個人私隱,CommonPass只會將用戶的個人識別資料和有限的新型冠狀病毒病相關記錄儲存於個人設備上。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.